Third-line tocilizumab for refractory pediatric anti-NMDA receptor encephalitis: a single-center case series.

Rituxan (rituximab) - Roche

Actemra IV (tocilizumab) - Roche, JW Pharma, Chugai Pharmaceutical

http://www.ncbi.nlm.nih.gov/pubmed/42767092

Andrea Del Rocio Quiroz Saavedra; Andrea G Savransky; Maria Celeste Buompadre; Maria Luz Monti; María Paula Ramos; Rocio Victoria Garcia; Silvia N Tenembaum

Sep 22, 2026